NEXT
Sign in to follow

New Jersey Law Journal

Bristol-Myers' $74B Deal to Buy Celgene Prompts Investor Suit

According to the complaint, Celgene and its directors held the deal out as a premium to its stockholders, despite allegedly rejecting a previous offer from Bristol-Myers with an aggregate value of $110 per share.
4 minute read

New York Law Journal

Federal Circuit May Decide Whether Successful IPR Petitioners Are Estopped from Using Winning Prior Art Combinations in Parallel District Court Litigation

Intellectual Property Litigation columnists Lewis R. Clayton and Eric Alan Stone discuss 'BTG Int'l Ltd. v. Amneal Pharm.', in which the Federal Circuit may decide whether §315(e)(2) acts to bar a successful IPR petitioner from asserting in district court the arguments on which it prevailed before the PTAB.
9 minute read

Delaware Business Court Insider

Investor Sues Over Bristol-Myers' $74B Deal to Buy Cancer Drug Maker

According to the complaint, Celgene and its directors held the deal out as a premium to its stockholders, despite allegedly rejecting a previous offer from Bristol-Myers with an aggregate value of $110 per share.
4 minute read

Delaware Business Court Insider

Takeda Unit Asks Judge to Wipe Out $155M Infringement Verdict Over Hemophilia Drug

In a court filing Friday, Baxalta Inc. argued that Bayer's patent was invalid and that the German-based pharmaceutical firm had presented no evidence to support the jury's damages award.
3 minute read

New York Law Journal

Legal Malpractice Suit Against Lowenstein Sandler Tossed by Appeals Court, Which Called It 'Speculative'

A former pharmaceuticals company officer had sued Lowenstein Sandler, claiming the firm failed to give him important tax advice about potential tax consequences tied to exercising company stock options as he departed the company.
4 minute read

New Jersey Law Journal

Judge Rejects Plaintiff Firms' Demand for More Fees in Merck Securities MDL

The Whitehead Law Firm of Lafayette, Louisiana, and Goforth Lewis & Sanford of Houston claimed they had a fee-sharing deal with New York's Stull, Stull & Brody when the firms teamed up on securities litigation against Merck & Co.
4 minute read

Legaltech News

Hashtagging Your Health: Instagram Influencers and Medical Promotions

It's no surprise that businesses have attempted to capitalize on that reach by partnering with 'influencers,' but when pharmaceutical companies and health startups use influencer-advertising, do some details get lost in the posting?
6 minute read

Law.com

Purdue Pharma, Amid Bankruptcy Whispers, Seeks Delay of Okla. Opioid Trial

Purdue Pharma has sought to delay a May 28 trial against the Oklahoma AG, citing a “belated tidal wave of documents,” but the move comes amid reports of its possible Chapter 11 bankruptcy.
5 minute read

Litigation Daily

Amid Bankruptcy Whispers, Purdue Pharma Seeks Delay of Okla. Opioid Trial

Purdue Pharma has sought to delay a May 28 trial against the Oklahoma AG, citing a “belated tidal wave of documents,” but the move comes amid reports of its possible Chapter 11 bankruptcy.
5 minute read

Law.com

Hashtagging Your Health: Instagram Influencers and Medical Promotions

It's no surprise that businesses have attempted to capitalize on that reach by partnering with “influencers,” but when pharmaceutical companies and health startups use influencer-advertising, do some details get lost in the posting?
6 minute read

More from ALM

More from ALM

Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

Resources

  • The Power of Online Reputation Management For Attorneys: A Critical Tool For Law Firms in 2025

    Brought to you by Erase.com

    Download Now

  • The Role of Evolving Support Structures in Optimizing Legal Talent

    Brought to you by BigHand

    Download Now

  • Corporate Monitorship Advisory Services

    Brought to you by HaystackID

    Download Now

  • AI-Powered Deposition and Medical Record Summaries: Low Risk, High Reward

    Brought to you by Parrot

    Download Now